Blood cancer Clinical Trials in Austin, TX
As of August 2026, 23 paid clinical trials are recruiting for Blood cancer in Austin, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Austin
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
24 clinical trials for Blood cancer
·Clear filters·A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Top Research Study Locations in Austin
Researchers run research studies in Austin, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dell Children's Medical Center of Central Texas | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 33 |
| The University of Texas at Austin | Attention Deficit Hyperactivity Disorder, Healthy, Multiple Sclerosis | 23 |
| University of Texas at Austin | Stroke, Alcohol Drinking, Alzheimer Disease | 23 |
| FutureSearch Trials of Neurology | Osteoarthritis, Knee, Chronic Pain, Migraine | 14 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Asthma | 13 |
| Texas Cardiac Arrhythmia Research Foundation | Atrial Fibrillation, Heart Failure, Paroxysmal AF | 12 |
| Dell Children's Medical Center | AAOCA, Acute Treatment of Migraine, Adolescent Idiopathic Scoliosis | 11 |
| Austin Clinical Trial Partners | Major Depressive Disorder, Depression, Generalized Anxiety Disorder | 10 |
| Austin Heart | Heart Failure, Obesity, Heart Failure With Preserved Ejection Fraction | 10 |
| Urology Austin | Prostate Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Bladder (Urothelial, Transitional Cell) Cancer | 10 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Advanced or Metastatic Renal Cell Carcinoma | 9 |
| NEXT Austin | Advanced Solid Tumors, Endometrial Cancer, Advanced Solid Tumor | 9 |
| Texas Oncology - Central/South Texas | Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer | 8 |
| National Neuromuscular Research Institute | Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis | 8 |
| Austin Retina Associates | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD) | 7 |
| St. David's South Austin Medical Center | AML, MDS, Multiple Myeloma | 7 |
| Texas Oncology | Any Solid Oral Medication, CRC (Colorectal Cancer), HER2-low Hormone Receptor Positive Breast Cancer | 7 |
| Ascension Texas Cardiovascular | Aortic Valve Stenosis, Cardiovascular Diseases, Pulmonary Hypertension | 6 |
| IMA Clinical Research Austin | Obesity, Overweight, Liver Fibrosis | 6 |
| NEXT Oncology | Locally Advanced (Unresectable) or Metastatic Solid Tumors, Ovarian Cancer, Solid Tumor | 6 |
| University of Texas | Logopenic Progressive Aphasia, Logopenic Progressive Aphasia (LPA), Logopenic Variant Primary Progressive Aphasia | 6 |
| Austin Neuromuscular Center | Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) | 5 |
| Austin Clinical Research, LLC | Diabetic Macular Edema, Geographic Atrophy, Macular Edema | 5 |
| Dell Children's Blood and Cancer Center | Neuroblastoma, Medulloblastoma, Pediatric Cancer | 5 |
| Dell Seton Medical Center at The University of Texas | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 5 |
Active & Upcoming Studies in Austin (2026)
Recruiting trials in Austin grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (172 active studies)
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Neurology & pain (51 active studies)
- Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children · Baylor College of Medicine
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
Diabetes & metabolic (50 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
Mental health & behavior (49 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Self-Compassion, Health, and Empowerment · Yang Li
Cardiovascular (44 active studies)
- Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation · Boston Scientific Corporation
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Eye & vision (23 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Pediatric (12 active studies)
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
- Pressure Targeting During High Flow Therapy in Premature Infants · Phase 2 · University of Texas at Austin
Vaccines (4 active studies)
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older · Phase 1, Phase 2 · Sanofi
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
HIV / STI (4 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Common conditions studied in Austin
- Obesity (22 active studies)
- Overweight (17 active studies)
- Heart Failure (16 active studies)
- Endometrial Cancer (13 active studies)
- Breast Cancer (12 active studies)
- Schizophrenia (12 active studies)
Leading research sponsors in Austin
- University of Texas at Austin
- AbbVie
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Austin?
There are approximately 683 recruiting clinical trials in Austin, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Austin pay participants?
Most recruiting trials in Austin compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Austin?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Austin?
The most common conditions under active study in Austin include Obesity (22), Overweight (17), Heart Failure (16), Endometrial Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Austin?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Austin on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Austin?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Austin?
Recruiting research sites in Austin include Dell Children's Medical Center of Central Texas, The University of Texas at Austin, University of Texas at Austin, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Austin right now?
The largest active categories in Austin are Cancer & tumors (172), Neurology & pain (51), Diabetes & metabolic (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.